Terms: = Breast cancer AND GATA2, NFE1B, 2624, ENSG00000179348, MGC2306, P23769 AND Treatment
5 results:
1. Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real-world clinical tumor sequencing study.
Huang Y; Qiu Y; Ding L; Ren S; Jiang Y; Luo J; Huang J; Yin X; Fu S; Zhao J; Hu K; Liao J
J Pathol Clin Res; 2024 Mar; 10(2):e12367. PubMed ID: 38504382
[TBL] [Abstract] [Full Text] [Related]
2. 5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells.
Greville G; Llop E; Howard J; Madden SF; Perry AS; Peracaula R; Rudd PM; McCann A; Saldova R
Clin Epigenetics; 2021 Feb; 13(1):34. PubMed ID: 33579350
[TBL] [Abstract] [Full Text] [Related]
3. Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome.
Haldar R; Shaashua L; Lavon H; Lyons YA; Zmora O; Sharon E; Birnbaum Y; Allweis T; Sood AK; Barshack I; Cole S; Ben-Eliyahu S
Brain Behav Immun; 2018 Oct; 73():294-309. PubMed ID: 29800703
[TBL] [Abstract] [Full Text] [Related]
4. Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in breast cancer Patients in a Phase-II Randomized Trial.
Shaashua L; Shabat-Simon M; Haldar R; Matzner P; Zmora O; Shabtai M; Sharon E; Allweis T; Barshack I; Hayman L; Arevalo J; Ma J; Horowitz M; Cole S; Ben-Eliyahu S
Clin Cancer Res; 2017 Aug; 23(16):4651-4661. PubMed ID: 28490464
[No Abstract] [Full Text] [Related]
5. ET-1 expression and growth inhibition of prostate cancer cells: a retinoid target with novel specificity.
Hsu JY; Pfahl M
Cancer Res; 1998 Nov; 58(21):4817-22. PubMed ID: 9809984
[TBL] [Abstract] [Full Text] [Related]
